SCHEMBL4809936

SCHEMBL4809936

Oc1ccc(-c2nc3cc(F)ccc3s2)cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.60
APP P05067 10/20 0.52
SULT1A1 P50225 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
DYRK1A Q13627 2/20 0.49
SNCA P37840 1/20 0.49
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11188660 0.87 AHR (0.56) AHRAPPSULT1A1HDAC3HDAC1
SCHEMBL4804942 0.84 APP (0.68) AHRAPPSULT1A1HDAC3HDAC1
SCHEMBL4803129 0.84 AHR (0.79) AHRAPPSULT1A1DYRK1AKDM4E
SCHEMBL4803017 0.84 AHR (0.79) AHRAPPSULT1A1HDAC3HDAC1
SCHEMBL12470524 0.82 GAA (0.60) APPSNCAKDM4EALDH1A1MAPT
SCHEMBL12470892 0.81 ILK (0.50) AHRAPPHDAC3HDAC1HDAC2
SCHEMBL4797697 0.81 NFKB1 (0.68) AHRAPPSULT1A1HDAC3HDAC1
SCHEMBL12470903 0.80 KDM4E (0.69) APPSNCAKDM4EALDH1A1MAPT
SCHEMBL30466258 0.80 KDM4E (0.69) APPSNCAKDM4EALDH1A1MAPT
SCHEMBL5691159 0.78 APP (0.77) AHRAPPSULT1A1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384966-B2 2-arylbenzothiazole derivatives PHARMINXO LIMITED (GB) 2008-06-10 US disclosed
US-20060063816-A1 2-Arylbenzothiazole derivatives STEVENS MALCOLM F G 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063816-A1 2-Arylbenzothiazole derivatives CX3CR1, HCN2, CYBB AHR 60/4885APP 1876/4885SULT1A1 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.